Table 1.

Demographic and clinical data of women—participants in the observational study on the oxidative markers and TNF-alpha apoptosis ligands in HPV infections associated with cervical carcinogenesis.

Group	Number of Subjects	Age Range
HPV10, HPV13, healthy	42	21–44 year
HPV16, HPV18, CIN I + CIN II	75	24–45 year
HPV16, HPV18, CIN III	45	28–53 year
Healthy female controls	15	25–47 year